The Lutein industry is projected to expand significantly, reaching a value of $653.9 million by the year 2034, with a consistent annual growth rate of 6.1%.
Europe dominates the Lutein Market, accounting for a significant 46.2% share, valued at USD 167.1 million in 2024. This leadership position is supported by investments from major players such as DSM, BASF, Kemin Industries, and Chr. Hansen, who have been actively involved in the processing and marketing of lutein.
The Lutein Market's growth is driven by a variety of factors, including funding and investments from companies like ARTAH Nutrition, HealthKart, MDARD, Cano-ela, and BinSentry. The market expansion is also fueled by growing awareness of natural antioxidants and the rising focus on nutrition-based lifestyles.
In 2024, Dietary Supplements led the Lutein Market by application with a 46.7% share. The Powder segment, on the other hand, led the market by form with a 38.4% share.
Lutein, a vital compound for eye health, plays a crucial role in protecting the retina from blue light and oxidative stress. It also filters out harmful blue light in the eyes, improving visual functions such as contrast sensitivity and reducing glare. Beyond vision, lutein contributes to cognitive function and skin health. It has been linked to better memory, thinking skills, and attention in older adults, supporting cognitive function.
Oral supplementation with lutein improves skin tone and brightness, and protects the skin from UV-related damage. This antioxidant also has anti-inflammatory effects, helping neutralize harmful molecules and reducing inflammation.
The market is projected to grow at a CAGR of 6.1% from 2025 to 2034, with the Global Lutein Market expected to reach USD 653.9 million by 2034. This growth is partly due to the increasing incidence of eye disorders like age-related macular degeneration and cataracts.
Emerging evidence suggests that lutein may also have benefits in areas like cardiovascular health and metabolic health. In October 2024, Kemin supported a clinical trial that demonstrated significant increases in carotenoid levels and improvements in infant eye development using FloraGLO® Lutein and OPTISHARPTM Natural Zeaxanthin in prenatal supplements.
However, challenges persist, such as the impact of production disruptions, as seen in BASF's force majeure declaration for selected vitamin A, vitamin E, and carotenoid products, including those related to lutein, due to a fire at its Ludwigshafen, Germany, plant in August 2024.
In conclusion, the Lutein Market continues to grow, driven by increasing awareness of its benefits for eye health, cognitive function, and skin health. The market's expansion is expected to continue, with a projected CAGR of 6.1% from 2025 to 2034.
Read also:
- New York City Council Proposes Legislation to Eliminate Fluoride from Public Water Supply
- Impact of Alcohol Consumption During Pregnancy: Consequences and Further Details
- The cause behind increased urination after alcohol consumption is explained here.
- Toe joint arthritis: Signs, triggers, and further details
